Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nua Biological Innovations is a Spanish laboratory specializing in the development and commercialization of high-purity, high-concentration food supplements, particularly marine Omega-3 fatty acids (DHA and EPA). Founded in 2008 and headquartered in Erandio, Spain, the company is a pioneer in separating DHA and EPA into distinct products to allow for targeted therapeutic effects. Their flagship brands, NuaDHA and NuaEPA, are recognized for their purity and have received the maximum 5-star IFOS certification and NSF Certified for Sport status. The company emphasizes research-driven formulations and conducts clinical trials in collaboration with prestigious medical institutions to validate the efficacy of its products in areas such as cognitive function, visual health, and fertility.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nua Biological Innovations.